Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Neurosteroids show promise for treating epilepsy and more research is needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Human hair follicles can make and process prostaglandins, which may affect hair growth.